Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Second-line therapy of idiopathic detrusor overactivity. Sacral neuromodulation and botulinum toxin A].

Literature DB >> 19859688

[Second-line therapy of idiopathic detrusor overactivity. Sacral neuromodulation and botulinum toxin A].

B Amend¹, D Castro-Diaz, E Chartier-Kastler, D De Ridder, K Everaert, M Spinelli, P van Kereebroeck, K-D Sievert.

Abstract

The syndrome of idiopathic overactive bladder (I-OAB) impairs quality of life for the affected individuals. Conservative treatment options such as antimuscarinics are not always effective, and resulting side effects can lead the patient to stop treatment. In recently years, minimally invasive and reversible sacral neuromodulation and botulinum toxin A have become available. Currently, the approved treatment option for I-OAB that is recommended by the International Consultation on Incontinence is sacral neuromodulation by InterStim therapy. This article gives an overview of the present clinical evidence on the effectiveness and reliability of these two treatment modalities as well as the current significance of sacral neuromodulation and botulinum toxin A for the second-line treatment of adult I-OAB.

Entities: Disease Species

Mesh：

Substances：

Year: 2010 PMID： 19859688 DOI： 10.1007/s00120-009-2139-5

Source DB: PubMed Journal: Urologe A ISSN： 0340-2592 Impact factor: 0.639

44 in total

1. Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group.

Authors: R A Schmidt; U Jonas; K A Oleson; R A Janknegt; M M Hassouna; S W Siegel; P E van Kerrebroeck
Journal: J Urol Date: 1999-08 Impact factor: 7.450

2. Complications and troubleshooting of two-stage sacral neuromodulation therapy: a single-institution experience.

Authors: Adonis Hijaz; Sandip P Vasavada; Firouz Daneshgari; Hasan Frinjari; Howard Goldman; Raymond Rackley
Journal: Urology Date: 2006-09-18 Impact factor: 2.649

3. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.

Authors: D M Schmid; P Sauermann; M Werner; B Schuessler; N Blick; M Muentener; R T Strebel; D Perucchini; D Scheiner; G Schaer; H John; A Reitz; D Hauri; B Schurch
Journal: J Urol Date: 2006-07 Impact factor: 7.450

Review 4. Current opinion on the working mechanisms of neuromodulation in the treatment of lower urinary tract dysfunction.

Authors: Floor van der Pal; John P F A Heesakkers; Bart L H Bemelmans
Journal: Curr Opin Urol Date: 2006-07 Impact factor: 2.309

5. Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study.

Authors: A C van Voskuilen; D J A J Oerlemans; E H J Weil; R A de Bie; Ph E V A van Kerrebroeck
Journal: Eur Urol Date: 2006-01-04 Impact factor: 20.096

6. Bladder pacemaker: scientific basis and clinical future.

Authors: E A Tanagho; R A Schmidt
Journal: Urology Date: 1982-12 Impact factor: 2.649

7. Medium-term experience of sacral neuromodulation by tined lead implantation.

Authors: Anco C Van Voskuilen; Dennis J A J Oerlemans; Ernest H J Weil; Ubi van den Hombergh; Philip E V A van Kerrebroeck
Journal: BJU Int Date: 2006-09-06 Impact factor: 5.588

8. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.

Authors: Gilles Karsenty; Ehab Elzayat; Thomas Delapparent; Benoît St-Denis; Marie-Claude Lemieux; Jacques Corcos
Journal: J Urol Date: 2007-03 Impact factor: 7.450